Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models
Fig 9
Fosmetpantotenate, PPA, and total PA in monkey blood and brain striatal dialysate.
Single oral administration to cynomolgus monkeys (100 and 300 mg/kg).